Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Immunovia AB appoints new CEO

April 29, 2023, Lund, Sweden  LUND, SWEDEN – As a next step in focusing on the US market The Board of Directors of Immunovia AB (Nasdaq Stockholm: IMMNOV), (publ) ("Immunovia" or the "Company") has today decided to appoint Jeff Borcherding, until now President of Immunovia’s US operation, as global CEO. Jeff Borcherding replaces Philipp Matthieu.   Jeff Borcherding has led Immunovia’s US business since April 2022. Prior to joining Immunovia, he held several positions in the American diagnostics industry, including most recently Chief Marketing Officer at Myriad Genetics. He will

Annual Report 2022: DecideAct came out of a turbulent year stronger

DecideAct A/S [ACT]Company Announcement No. 06-2023:NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN29 APRIL 2023 DecideAct’s annual report for the period January 1 to December 31, 2022, was approved by the Board of Directors today. The Report is attached to this release and can be read here: https://www.decideact.net/investor-relations/After a year marked by growth and turbulence, DecideAct is stronger than ever. Key metrics are 37% growth in gross ARR, a pipeline that has grown steadily, and more new deals in the contracting phase than ever before. Furthermore, the Company has

Noble Corporation plc announces changes to its share capital

SUGAR LAND, TEXAS, April 29, 2023 /CNW/ - Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today announces changes to its share capital. During the period since March 31, 2023, 37,180 new A ordinary shares each with a nominal value of USD 0.00001 have been issued.   313 new A ordinary shares have been issued to certain holders of warrants as a consequence of the exercise of warrants. The exercise price was USD 19.27 per A ordinary share for 311 of the new A ordinary shares and USD 124.40 per A ordinary share for 2 of the new A ordinary shares. The total proceeds to Noble from

Lundin Mining Announces Updated Share Capital and Voting Rights

TORONTO, April 28, 2023 /CNW / - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) reports the following updated share capital and voting rights, in accordance with the Swedish Financial Instruments Trading Act: The number of issued and outstanding shares of the Company has increased by 158,296 to 771,904,307 common shares with voting rights as at April 28, 2023. The increase in the number of issued and outstanding shares from April 1, 2023 to date is a result of the exercise of employee stock options or the vesting of employee share units.

Africa Oil Announces Further Investment in Impact Oil & Gas and Share Capital and Voting Rights Update

VANCOUVER, BC, April 28, 2023 /CNW/ (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, “AOC” or the “Company”) is pleased to announce that it has participated in a USD 95.0 million Open Offer by Impact Oil & Gas Limited (“Impact”), the privately‐owned, African‐focused exploration company. The capital raised shall be used towards funding Impact’s participating share of the multi-well drilling and testing programme in Namibia to further evaluate and appraise the Venus discovery; a world class, light-oil and associated gas field announced in February 2022[1]. Africa Oil is

Lundin Gold Share Capital and Voting Rights Update

VANCOUVER, BC, April 28, 2023 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") reports the following in accordance with the Swedish Financial Instruments Trading Act.   As a result of the exercises of stock options issued under Lundin Gold’s equity compensation plans during the month of April, the Company now has 236,763,453 common shares issued and outstanding with voting rights as at April 28, 2023.    This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are

Nordea Bank Abp: Repurchase of own shares on 28.04.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares28.04.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 28.04.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |109,431|10.05 |1,099,726.

poLight ASA: Results of the Rights Issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to previous stock exchange announcements from poLight ASA ("poLight" or the "Company") regarding a fully underwritten rights issue of 12,918,660 new shares in the Company (the "Offer Shares"), raising gross proceeds of NOK 135 million (the "Rights Issue"). The

Dentalum publishes Annual Report for 2022

Dentalum’s Annual Report for 2022 has been published and is now available on the company’s website.The Annual Report is published in Swedish and English and is available on Dentalum’s website: https://dentalum.com/financial-reports/  For further information, please contact Max Dorthé Ladow, CEO and co-founder, +46 709 85 97 83, max.ladow@dentalum.com Sofi Eriksson, acting CFO, +46 705 95 46 33, sofi.eriksson@dentalum.com For more information, please visit www.dentalum.com Dentalum Operations AB (publ) is a fast-growing dental service organisation focusing on acquiring

Asarina Pharma AB (publ) releases Annual Report 2022

(Stockholm, 28 April 2023) Asarina Pharma’s 2022 Annual Report contains analysis and insights into its recent positive Phase IIa results for Tourette syndrome, as well as 2022 financial statements and outlook. Additional content includes investor FAQs with CEO Peter Nordkild and clinical insights from Clinical Neurologist Dr Heidi Biernat (Head of the Tourette Clinic at Bispebjerg University Hospital) on today’s Tourette treatment landscape and patients’ experience of Sepranolone.The full Annual Report 2022 is available on: https://asarinapharma.com/investors/financial-reports/ Research

DDM Debt AB publishes its 2022 Annual report

DDM Debt AB (Nasdaq Stockholm: DDM Debt 2026) ("DDM Debt") today published its 2022 Annual report. The document is available on the DDM Group's website, www.ddm-group.ch . DDM Debt currently intends to publish financial information on the following dates in 2023: Interim report January – March 2023: 30 May 2023Annual General Meeting 2023: 29 June 2023Interim report January – June 2023: 31 August 2023Interim report January – September 2023: 30 November 2023

DDM Holding AG publishes its 2022 Annual report

DDM Holding AG (First North Growth Market: DDM) today published its 2022 Annual report. The document is available on the DDM Group's website, www.ddm-group.ch . DDM currently intends to publish financial information on the following dates in 2023: Interim report January – March 2023: 30 May 2023Annual General Meeting 2023: 29 June 2023Interim report January – June 2023: 31 August 2023Interim report January – September 2023: 30 November 2023

Observe Medical Annual Report for 2022

Oslo, 28 April 2023 – Observe Medical ASA ("the Company" or "Observe Medical") today announces that the Company has published its Annual Report for 2022. The Annual Report was approved by the Board of Directors on 27 April 2023. “In 2022, Observe Medical explored several paths to broaden our product portfolio and secure production capacity. Throughout the year, we capitalised on several exciting opportunities, and I am grateful to the team at Observe Medical, who have met each opportunity and challenge without hesitation. Looking ahead, our ambition remains unchanged, and we continue to

poLight ASA - Annual Report 2022

Horten, 28 April 2023 - poLight ASA (OSE: PLT) today the Board of Directors approved the 2022 Annual Report. The financial statements are consistent with the preliminary report disclosed on 28 February 2023. The board does not propose a dividend. Attached is the Annual Report 2022 for poLight ASA. The report is also available at www.polight.com. This stock exchange notice is subject to the disclosure requirements in Section 5-12 of the Norwegian Securities Trading Act.

Q-Free: Annual report 2022

Q-Free ASA has today published its Annual Report for 2022 including the Corporate Governance Report, and its Corporate Social Responsibility Report for 2022. The reports are attached to this release and is also available on www.q-free.com  . Q-Free ASA has also published its annual financial statements in European Single Electronic format (ESEF), available as an attachment to this release. Trondheim, 28 April 2023 For further inquiries, please contact: President & CEO, Thale Kuvås Solberg, +47 936 80 030CFO, Trond

Annual General Meeting 2023 in Bluestep Bank AB (publ) and publication of Annual and Sustainability report for 2022

Bluestep Bank AB (publ)’s Annual General Meeting (AGM) was concluded on the 28th of April 2023. The AGM re-elected all six of the board members. The AGM also re-elected the auditor. Bluestep Bank AB (publ) also publishes the Annual and Sustainability report for 2022, which is available on the company’s website. Among other things, the AGM resolved the following: · The AGM approved the income statement and balance sheet for Bluestep Bank AB (publ) as well as the consolidated income statement and consolidated balance sheet. · The AGM approved that the appropriation of profits

Annual Report 2022 Glycorex Transplantation AB (publ)

Today Glycorex Transplantation AB (publ) publish the Annual Report for 2022. A pdf-version of the annual report in Swedish is enclosed to this press release. An English version will be available shortly on https://glycorex.com/investors/financial-reports/. For more information, please contact:Johan Lavén, CEOEmail: johan.laven@glycorex.comTel: + 46 (0)73 330 92 16 This information is the kind of information Glycorex Transplantation AB (publ) is obliged to make public under the EU Market Abuse Act and the Act on the Securities Market. The information was submitted for publication

#23-146 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Change of number of shares and votes in Instalco

Pursuant to the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument), Swedish companies whose shares are listed on a regulated market and who increases or reduces the total number of shares or votes in the company is to disclose such changes on the last trading day the same month.As of 28 April 2023, there are in total 261 575 900 shares and votes in Instalco AB (“Instalco” or the “Company”).   The change in number of shares and votes in the Company is a result of the board of directors’ decision to issue in total 1 011 880 new shares

Change in the number of shares and votes in Sinch AB (publ)

Stockholm, Sweden – 28 April 2023 – Sinch AB (publ), which powers meaningful conversations between businesses and their customers through its Customer Communications Cloud, today announced that the number of shares and votes in Sinch AB (publ), registration number 556882-8908 (“Sinch”), amounts to 839,622,828 on 28 April 2023. The change in the number of shares and votes in April is a result of 1,020,580 new shares issued upon exercise of warrants within the frame of incentive programs LTI 2018 and LTI 2019. For further information, please contact Ola ElmelandInvestor Relations

Number of shares and votes in CTEK

The number of shares and votes in CTEK AB (publ) (“CTEK”) have changed as a result of new shares being issued in the rights issue resolved by the board of directors on 8 February 2023, subject to approval from the extraordinary general meeting on 3 March 2023. Through the rights issue, the number of outstanding shares and votes have increased by 19,993,221, from 49,983,054 to 69,976,275. The share capital has increased by SEK 19,993,221, from SEK 49,983,054 to SEK 69,976,275.

There are no items matching the current filter
There are no more items matching the current filter
Back to top